Tyra Biosciences (TYRA)
(Delayed Data from NSDQ)
$16.11 USD
-1.04 (-6.06%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $16.09 -0.02 (-0.12%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (87 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.38 | 9.99 |
Current Quarter Estimate | -0.43 | -2.62 | 63.00 |
Year Ago Quarter Estimate | -0.53 | -4.94 | 52.25 |
Next Quarter Estimate | -0.43 | 2.79 | 66.00 |
Next Year Estimate | -1.90 | 21.45 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 5.56 | 16.60 | 15.67 |
Next Year | -24.18 | 9.80 | 11.34 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | NA | 21.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -8.36 |
Price/Book (MRQ) | 2.40 | 2.07 |
Price/Cash Flow (MRFY) | NA | 15.35 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -15.58% |
Return on Equity (TTM) | -25.30% | -14.63% |
Debt to Equity (MRQ) | NA | 4.66 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.